Pharming Group N.V. (PHAR) Presents at 25th Annual Needham Virtual Healthcare Conference - Slideshow

Pharming Group N.V. presented at the 25th Annual Needham Virtual Healthcare Conference in April 2026, showcasing its latest corporate and pipeline updates via a slide deck. The presentation focused on the company’s rare disease therapies, including its flagship product Ruconest for hereditary angioedema, highlighting commercial performance and market expansion strategies. Key financial metrics were addressed, with emphasis on revenue growth projections, R&D investments, and operational milestones for 2026 and beyond. Pharming outlined progress in its clinical pipeline, including late-stage trials for new indications and potential regulatory submissions in the near term. The event underscored Pharming’s commitment to innovation in rare disease treatments, positioning itself as a leader in specialized biopharmaceuticals.